Stock Analysts’ new coverage for Wednesday, August 16th:
Evercore ISI initiated coverage on shares of AbbVie (NYSE:ABBV). They issued an outperform rating on the stock.
Evercore ISI initiated coverage on shares of Alexion Pharmaceuticals (NASDAQ:ALXN). They issued a $137.00 target price on the stock.
Evercore ISI initiated coverage on shares of Bioverativ (NASDAQ:BIVV). They issued a $58.00 price target on the stock.
Evercore ISI started coverage on shares of bluebird bio (NASDAQ:BLUE). Evercore ISI issued a $102.00 price target on the stock.
Evercore ISI started coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN). Evercore ISI issued an outperform rating on the stock.
Evercore ISI initiated coverage on shares of Audentes Therapeutics (NASDAQ:BOLD). They issued an outperform rating on the stock.
Evercore ISI assumed coverage on shares of Clovis Oncology (NASDAQ:CLVS). The firm issued a $73.00 target price on the stock.
Evercore ISI began coverage on shares of GW Pharmaceuticals PLC (NASDAQ:GWPH). They issued an outperform rating on the stock.
Evercore ISI started coverage on shares of Incyte Corporation (NASDAQ:INCY). Evercore ISI issued a $135.00 target price on the stock.
Evercore ISI assumed coverage on shares of Insmed (NASDAQ:INSM). They issued an outperform rating on the stock.
Evercore ISI started coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS). Evercore ISI issued an outperform rating on the stock.
DA Davidson assumed coverage on shares of Medifast (NYSE:MED). The firm issued a buy rating on the stock.
Evercore ISI started coverage on shares of Myovant Sciences (NASDAQ:MYOV). Evercore ISI issued an outperform rating on the stock.
Evercore ISI assumed coverage on shares of NASDAQ 100 Ex Tech Total Return (NASDAQ:NXTR). Evercore ISI issued a $20.00 price target on the stock.
Evercore ISI initiated coverage on shares of Spark Therapeutics (NASDAQ:ONCE). The firm issued a $83.00 price target on the stock.
Evercore ISI assumed coverage on shares of Prothena Corporation PLC (NASDAQ:PRTA). The firm issued an outperform rating on the stock.
Evercore ISI started coverage on shares of Ultragenyx Pharmaceutical (NASDAQ:RARE). Evercore ISI issued a $63.00 price target on the stock.
Evercore ISI initiated coverage on shares of Regeneron Pharmaceuticals (NASDAQ:REGN). The firm issued an outperform rating on the stock.
Evercore ISI assumed coverage on shares of REGENXBIO (NASDAQ:RGNX). They issued an outperform rating on the stock.
Evercore ISI initiated coverage on shares of Shire PLC (NASDAQ:SHPG). They issued an outperform rating on the stock.
Evercore ISI initiated coverage on shares of Theravance Biopharma (NASDAQ:TBPH). The firm issued an outperform rating on the stock.
Evercore ISI initiated coverage on shares of TESARO (NASDAQ:TSRO). Evercore ISI issued a $121.00 target price on the stock.
Evercore ISI started coverage on shares of Voyager Therapeutics (NASDAQ:VYGR). The firm issued an outperform rating on the stock.
